[go: up one dir, main page]

ATA185885A - Verfahren zur herstellung des neuen 3-amino-4-(2-((2-guanidinothiazol-4-yl)methylth o)-ethylamino)-1,2,5-thiadiazols - Google Patents

Verfahren zur herstellung des neuen 3-amino-4-(2-((2-guanidinothiazol-4-yl)methylth o)-ethylamino)-1,2,5-thiadiazols

Info

Publication number
ATA185885A
ATA185885A AT0185885A AT185885A ATA185885A AT A185885 A ATA185885 A AT A185885A AT 0185885 A AT0185885 A AT 0185885A AT 185885 A AT185885 A AT 185885A AT A185885 A ATA185885 A AT A185885A
Authority
AT
Austria
Prior art keywords
guanidinothiazol
methylth
thiadiazol
ethylamino
amino
Prior art date
Application number
AT0185885A
Other languages
English (en)
Other versions
AT390790B (de
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Priority to AT0179289A priority Critical patent/ATA179289A/de
Priority to AT0260889A priority patent/ATA260889A/de
Publication of ATA185885A publication Critical patent/ATA185885A/de
Application granted granted Critical
Publication of AT390790B publication Critical patent/AT390790B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/101,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/44Acylated amino or imino radicals
    • C07D277/48Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AT0185885A 1984-06-22 1985-06-21 Verfahren zur herstellung des neuen 3-amino-4-(2-((2-guanidinothiazol-4-yl)methylth o)-ethylamino)-1,2,5-thiadiazols AT390790B (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AT0179289A ATA179289A (de) 1984-06-22 1989-07-25 Verfahren zur herstellung des neuen n-(2-((2guanidinothiazol-4-yl)methyl-thio)ethyl)ethandiimidamids
AT0260889A ATA260889A (de) 1984-06-22 1989-11-15 Verfahren zur herstellung des neuen n-(2-( (2-guanidinothiazol-4-yl)methylthio)-ethyl)- ethandiimidamids

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/623,588 US4644006A (en) 1984-06-22 1984-06-22 Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity

Publications (2)

Publication Number Publication Date
ATA185885A true ATA185885A (de) 1989-12-15
AT390790B AT390790B (de) 1990-06-25

Family

ID=24498651

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0185885A AT390790B (de) 1984-06-22 1985-06-21 Verfahren zur herstellung des neuen 3-amino-4-(2-((2-guanidinothiazol-4-yl)methylth o)-ethylamino)-1,2,5-thiadiazols

Country Status (33)

Country Link
US (1) US4644006A (de)
JP (2) JPS6118775A (de)
KR (1) KR900004321B1 (de)
AR (1) AR240935A1 (de)
AT (1) AT390790B (de)
AU (2) AU580605B2 (de)
BE (1) BE902724A (de)
CA (2) CA1267412A (de)
CH (1) CH665210A5 (de)
CS (1) CS257276B2 (de)
DD (1) DD240889A5 (de)
DE (1) DE3522101A1 (de)
DK (1) DK282885A (de)
ES (2) ES8702902A1 (de)
FI (1) FI852405L (de)
FR (1) FR2566406B1 (de)
GB (2) GB2161157B (de)
GR (1) GR851514B (de)
HU (1) HU193992B (de)
IE (2) IE57937B1 (de)
IL (1) IL75567A0 (de)
IT (1) IT1190372B (de)
LU (1) LU85969A1 (de)
NL (1) NL8501766A (de)
NO (1) NO161856C (de)
NZ (1) NZ212403A (de)
OA (1) OA08039A (de)
PT (1) PT80684B (de)
SE (1) SE464305B (de)
SU (1) SU1537136A3 (de)
YU (2) YU45725B (de)
ZA (1) ZA854710B (de)
ZW (1) ZW10385A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991018882A1 (en) * 1990-05-29 1991-12-12 Nippon Soda Co., Ltd. N-substituted heterocyclic amidine derivative
EP4196793A1 (de) 2020-08-11 2023-06-21 Université de Strasbourg Auf lebermakrophagen abzielende h2-blocker zur prävention und behandlung von lebererkrankungen und krebs

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3657237A (en) * 1968-05-22 1972-04-18 Frosst & Co Charles E Process for making 1 2 5-thiadiazoles in the sinister configuration
DK160611C (da) * 1979-09-04 1991-09-16 Bristol Myers Squibb Co Analogifremgangsmaade til fremstilling af 3,4-disubstituerede 1,2,5-thiadiazol-1-oxider og -1,1-dioxider
EP0040696B1 (de) * 1980-04-30 1986-08-27 Merck & Co. Inc. Aminothiadiazole als gastrische Inhibitoren
US4394508A (en) * 1980-06-07 1983-07-19 Bristol-Myers Company Chemical compounds
DE3168031D1 (en) * 1980-07-30 1985-02-14 Ici Plc Guanidine derivatives
EP0060730A3 (de) * 1981-03-18 1982-12-08 Imperial Chemical Industries Plc Bicyclische Derivate
EP0065823A1 (de) * 1981-05-13 1982-12-01 Imperial Chemical Industries Plc Heterozyklische Guanidinderivate als Histamin-H-2-Antagonisten
FR2542741B1 (fr) * 1982-03-29 1989-12-08 Bristol Myers Co 3,4-diamino-1,2,5-thiadiazoles substitues possedant une activite antagoniste du recepteur-h2 de l'histamine
US4588826A (en) * 1982-03-29 1986-05-13 Bristol-Myers Company Ethanediimidamide intermediates
US4528377A (en) * 1982-03-29 1985-07-09 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
US4517366A (en) * 1982-03-29 1985-05-14 Bristol-Myers Company Intermediates for preparing 3,4-diamino-1,2,5-thiadiazoles
US4528378A (en) * 1982-03-29 1985-07-09 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
US4528375A (en) * 1982-03-29 1985-07-09 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
FI832519L (fi) * 1982-07-12 1984-01-13 Bristol Myers Co Farmaceutiska foerfaranden och sammansaettningar
US4520025A (en) * 1982-07-21 1985-05-28 William H. Rorer, Inc. Bicyclic nitrogen heterocyclic ethers and thioethers, and their pharmaceutical uses
JPS5978171A (ja) * 1982-10-26 1984-05-04 Ikeda Mohandou:Kk 複素環式化合物
US4440933A (en) * 1983-03-16 1984-04-03 Bristol-Myers Company Process for preparing 1,2,5-thiadiazoles

Also Published As

Publication number Publication date
DK282885A (da) 1985-12-23
NL8501766A (nl) 1986-01-16
NO161856C (no) 1989-10-04
YU105185A (en) 1987-12-31
US4644006A (en) 1987-02-17
HU193992B (en) 1987-12-28
OA08039A (fr) 1987-01-31
LU85969A1 (fr) 1986-01-24
YU45725B (sh) 1992-07-20
GR851514B (de) 1985-11-25
IL75567A0 (en) 1985-10-31
CH665210A5 (de) 1988-04-29
JPS6118775A (ja) 1986-01-27
HUT42087A (en) 1987-06-29
AT390790B (de) 1990-06-25
KR900004321B1 (ko) 1990-06-22
SE8503110D0 (sv) 1985-06-20
ZW10385A1 (en) 1986-02-05
KR860000275A (ko) 1986-01-27
AU2977589A (en) 1989-06-01
GB2161157B (en) 1988-08-10
IE58261B1 (en) 1993-08-25
IT8521217A0 (it) 1985-06-20
SE464305B (sv) 1991-04-08
FR2566406B1 (fr) 1988-01-29
AU580605B2 (en) 1989-01-19
GB2161157A (en) 1986-01-08
GB8515749D0 (en) 1985-07-24
AR240935A1 (es) 1991-03-27
ES8702881A1 (es) 1987-01-16
YU102587A (en) 1988-02-29
ES8702902A1 (es) 1987-01-16
ZA854710B (en) 1986-02-26
SU1537136A3 (ru) 1990-01-15
AU4392085A (en) 1986-01-02
DK282885D0 (da) 1985-06-21
ES544409A0 (es) 1987-01-16
JPS61186369A (ja) 1986-08-20
CA1267412A (en) 1990-04-03
NO161856B (no) 1989-06-26
CS424785A2 (en) 1987-09-17
SE8503110L (sv) 1985-12-23
DE3522101A1 (de) 1986-01-02
AU614331B2 (en) 1991-08-29
CA1297875C (en) 1992-03-24
PT80684A (en) 1985-07-01
ES551506A0 (es) 1987-01-16
IE851557L (en) 1985-12-22
IE57937B1 (en) 1993-05-19
AR240935A2 (es) 1991-03-27
PT80684B (en) 1987-05-08
DD240889A5 (de) 1986-11-19
NZ212403A (en) 1989-04-26
FI852405L (fi) 1985-12-23
FR2566406A1 (fr) 1985-12-27
YU45822B (sh) 1992-07-20
GB8716149D0 (en) 1987-08-12
BE902724A (fr) 1985-12-23
IT1190372B (it) 1988-02-16
FI852405A0 (fi) 1985-06-17
CS257276B2 (en) 1988-04-15
GB2192884B (en) 1988-08-10
NO852519L (no) 1985-12-23
GB2192884A (en) 1988-01-27

Similar Documents

Publication Publication Date Title
DE59000326D1 (de) Verfahren zur herstellung von 3-amino-5-aminocarbonyl-1,2,4-triazol-derivaten.
DE3675687D1 (de) Verfahren zur herstellung von 2,2,6,6,-tetraalkyl-4-piperidylamine.
AT386414B (de) Verfahren zur herstellung des neuen 2'-acetylery- thromycinstearates
DE3667167D1 (de) Verfahren zur herstellung von 1,5-diazido-3-nitrazapentan.
DE3677272D1 (de) Verfahren zur herstellung von 2,2,6,6-tetraalkyl-4-piperidylaminen.
DE3676215D1 (de) Verfahren zur herstellung von 2,3,4,5-tetrafluorbenzoesaeure.
DE3680454D1 (de) Verfahren zur herstellung von halogenhaltigen (2,2)-paracyclophanen.
DE3860671D1 (de) Verfahren zur herstellung von 2,6-dialkylnaphthalin.
DE3674055D1 (de) Verfahren zur herstellung von 1,3,5-triazintrionen.
DE3861825D1 (de) Verfahren zur herstellung von (2,2)-paracyclophan.
DE3673049D1 (de) Verfahren zur herstellung von 1,3-dialkyl-2-imidazolidinon.
DE3581884D1 (de) Verfahren zur herstellung von 2,2'-methylen-bis-(4-hydrocarbyl-6-benzotriazolyl(phenolen).
DE3765956D1 (de) Verfahren zur herstellung von 1-methyl-3,5,7-triaza-1-azoniatricyclodecan-halogeniden.
DE58901165D1 (de) Verfahren zur herstellung von 2,4-dihydroxybenzoesaeure.
AT373892B (de) Verfahren zur herstellung des neuen kristallinen 1,1-dioxopenicillanoyloxymethyl-6-(d-alpha-amin
DE3669148D1 (de) Verfahren zur herstellung von 4,4'-dinitrodibenzylen.
AT387776B (de) Verfahren zur herstellung von neuem 8alphapivaloylamino-9,10-didehydro-ergolin
ATA185885A (de) Verfahren zur herstellung des neuen 3-amino-4-(2-((2-guanidinothiazol-4-yl)methylth o)-ethylamino)-1,2,5-thiadiazols
DE3671436D1 (de) Verfahren zur herstellung von 2,2,-dibrom-3-oxonitrilen.
AT380881B (de) Verfahren zur herstellung des neuen 3-(4-phenyl-1-piperazinio-1-yl)-1,2-propandiol-(theophyllin-7-yl)-1-propansulfonats
AT374203B (de) Verfahren zur herstellung von neuen 2'-desoxy-3', 5'-di-o-alkylcarbonyl-5-fluoruridinderivaten
AT380233B (de) Verfahren zur herstellung von neuen 1,7,7
AT371442B (de) Verfahren zur herstellung des neuen 1-(2-chlorbenzyl)-1,2,3,6-tetrahydropyridins
AT388730B (de) Verfahren zur herstellung von neuen azabicyclo (3,3,1) - nonan- derivaten
DE3574585D1 (de) Verfahren zur herstellung von 3,5-dialkyl-4-hydroxybenzoesaeure.

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
REN Ceased due to non-payment of the annual fee